Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CTS-21166 reduces plasma amyloid beta in phase I study

Jan. 11, 2008

Pipex initiates phase II trial of anti-copper Coprexa for Alzheimer's disease

Jan. 11, 2008

Quetiapine treatment assessed in depression, anxiety and alcoholism

Jan. 11, 2008

Iloperidone effective in double-blind schizophrenia trials

Jan. 11, 2008

Erythropoietin may have antidepressant activity

Jan. 11, 2008

Therapeutic potential of GLS1 inhibition in schizophrenia

Jan. 10, 2008

Ambien CR tablets CIV improve chronic insomnia in GAD patients

Jan. 10, 2008

Alseres completes enrollment in phase I/IIa clinical trial of Cethrin and plans phase IIb trial

Jan. 10, 2008

New ferritin light chain gene mutant mice, useful to study neuroferritinopathy / News in Context

Jan. 9, 2008

Melanin-concentrating hormone, a potential antidepressant target

Jan. 9, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026